{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:25:53Z","timestamp":1794050753399,"version":"4.8.0"},"reference-count":247,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"DOI":"10.1186\/s12891-024-08180-9","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T14:46:03Z","timestamp":1734619563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Gout: global epidemiology, risk factors, comorbidities and complications: a narrative review"],"prefix":"10.1186","volume":"25","author":[{"given":"Kimia Motlagh","family":"Asghari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Zahmatyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Seyedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Motamedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh","family":"Zolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina Janbaz","family":"Alamdary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asra","family":"Fazlollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shamekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ehsan","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Aria","family":"Nejadghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mohammadinasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Ghazi-Sha\u2019rbaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Karamzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J. M.","family":"Sullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali-Asghar","family":"Kolahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Safiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"8180_CR1","doi-asserted-by":"crossref","unstructured":"Doherty M. New insights into the epidemiology of gout. Rheumatology. 2009;48(suppl_2):ii2-ii8.","DOI":"10.1093\/rheumatology\/kep086"},{"key":"8180_CR2","doi-asserted-by":"crossref","unstructured":"Roddy E, Doherty M. Gout. Epidemiology of gout. Arthritis research & therapy. 2010;12(6):1\u201311.","DOI":"10.1186\/ar3199"},{"issue":"1","key":"8180_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.semarthrit.2019.07.002","volume":"50","author":"C Yokose","year":"2020","unstructured":"Yokose C, Dalbeth N, Wei J, Nicolaou S, Simeone FJ, Baumgartner S, et al. Radiologic evidence of symmetric and polyarticular monosodium urate crystal deposition in gout - A cluster pattern analysis of dual-energy CT. Semin Arthritis Rheum. 2020;50(1):54\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"8180_CR4","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1007\/s11606-018-4662-9","volume":"33","author":"M Rosas","year":"2018","unstructured":"Rosas M, Aronowitz P. Gout In Extremis: Massive Soft Tissue Tophaceous Deposits. J Gen Intern Med. 2018;33(12):2248\u20139.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"8180_CR5","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74(10):1789\u201398.","journal-title":"Ann Rheum Dis"},{"key":"8180_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","volume":"77","author":"AK Mandal","year":"2015","unstructured":"Mandal AK, Mount DB. The molecular physiology of uric acid homeostasis. Annu Rev Physiol. 2015;77:323\u201345.","journal-title":"Annu Rev Physiol"},{"key":"8180_CR7","doi-asserted-by":"crossref","unstructured":"Dalbeth N, Choi HK, Joosten LA, Khanna PP, Matsuo H, Perez-Ruiz F, et al. Gout (Primer). Nature Reviews: Disease Primers. 2019.","DOI":"10.1038\/s41572-019-0115-y"},{"issue":"1","key":"8180_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/art.20761","volume":"52","author":"HK Choi","year":"2005","unstructured":"Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2005;52(1):283\u20139.","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"11","key":"8180_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"C-F Kuo","year":"2015","unstructured":"Kuo C-F, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649\u201362.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"8180_CR10","first-page":"1441","volume":"46","author":"E Roddy","year":"2007","unstructured":"Roddy E, Zhang W, Doherty M. Is gout associated with reduced quality of life? A case-control study Rheumatology. 2007;46(9):1441\u20134.","journal-title":"A case-control study Rheumatology"},{"issue":"9","key":"8180_CR11","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1136\/ard.2007.081604","volume":"67","author":"JA Singh","year":"2008","unstructured":"Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008;67(9):1310\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8180_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000504","volume":"5","author":"M Kolz","year":"2009","unstructured":"Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 2009;5(6): e1000504.","journal-title":"PLoS Genet"},{"issue":"5","key":"8180_CR13","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s10067-019-04520-6","volume":"38","author":"IJM Disveld","year":"2019","unstructured":"Disveld IJM, Zoakman S, Jansen TLTA, Rongen GA, Kienhorst LBE, Janssens HJEM, et al. Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and\/or high serum uric acid levels: a prospective cohort study. Clin Rheumatol. 2019;38(5):1385\u201391.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"8180_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13075-015-0610-9","volume":"17","author":"MJ Roughley","year":"2015","unstructured":"Roughley MJ, Belcher J, Mallen CD, Roddy E. Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies. Arthritis Res Ther. 2015;17(1):90.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"8180_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12886-018-0669-6","volume":"18","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Brenner JE, Foster WJ. Retinal complications of gout: a case report and review of the literature. BMC Ophthalmol. 2018;18(1):11.","journal-title":"BMC Ophthalmol"},{"key":"8180_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.33545\/26164485.2020.v4.i3f.238","volume":"4","author":"SS Rajan","year":"2020","unstructured":"Rajan SS, Shibina K. A case of gout trated with Homoeopathic constitutional remedy. International Journal of Homoeopathic Sciences. 2020;4:365\u20138.","journal-title":"International Journal of Homoeopathic Sciences"},{"issue":"3","key":"8180_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/archinte.1943.00210090078007","volume":"72","author":"E Neuwirth","year":"1943","unstructured":"Neuwirth E. Milestones in the diagnosis and treatment of gout. Arch Intern Med. 1943;72(3):377\u201387.","journal-title":"Arch Intern Med"},{"key":"8180_CR18","doi-asserted-by":"crossref","unstructured":"Copeman W. 2 Historical Aspects of Gout. Clinical Orthopaedics and Related Research\u00ae. 1970;71:14\u201322.","DOI":"10.1097\/00003086-197007000-00003"},{"key":"8180_CR19","doi-asserted-by":"crossref","unstructured":"Shebi S, Chokkattu JJ. An updated review on gout. International Journal of Health Sciences. (II):11950\u20137.","DOI":"10.53730\/ijhs.v6nS2.8230"},{"issue":"1","key":"8180_CR20","first-page":"83","volume":"9","author":"KC Gritzalis","year":"2011","unstructured":"Gritzalis KC, Karamanou M, Androutsos G. Gout in the writings of eminent ancient Greek and Byzantine physicians. Acta medico-historica Adriatica: AMHA. 2011;9(1):83\u20138.","journal-title":"Acta medico-historica Adriatica: AMHA"},{"issue":"4","key":"8180_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101716","volume":"35","author":"S Stewart","year":"2021","unstructured":"Stewart S, Dalbeth N, Gaffo A. The challenge of gout flare measurement. Best Pract Res Clin Rheumatol. 2021;35(4): 101716.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8180_CR22","doi-asserted-by":"crossref","unstructured":"Taylor WJ, Grainger R. Clinical features of gout. Gout and other crystal arthropathies 1st edition ed Philadelphia, USA: Elsevier Saunders. 2011:105\u201320.","DOI":"10.1016\/B978-1-4377-2864-4.10009-0"},{"issue":"5441","key":"8180_CR23","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/bmj.1.5441.1038","volume":"1","author":"A McFadzean","year":"1965","unstructured":"McFadzean A. A eunuch takes the gout. BMJ. 1965;1(5441):1038.","journal-title":"BMJ"},{"issue":"1","key":"8180_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar1906","volume":"8","author":"G Nuki","year":"2006","unstructured":"Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther. 2006;8(1):1\u20135.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"8180_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/andr.13088","volume":"10","author":"M Totaro","year":"2022","unstructured":"Totaro M, Dimarakis S, Castellini C, D\u2019Andrea S, Parisi A, D\u2019Amato F, et al. Erectile dysfunction in hyperuricemia: A prevalence meta-analysis and meta-regression study. Andrology. 2022;10(1):72\u201381.","journal-title":"Andrology"},{"issue":"7","key":"8180_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380\u201390.","journal-title":"Nat Rev Rheumatol"},{"key":"8180_CR27","unstructured":"Institute for Health Metrics and Evaluation (IHME). GBD Compare 2019 [Available from: http:\/\/vizhub.healthdata.org\/gbd-results\/."},{"issue":"1","key":"8180_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.semarthrit.2020.12.001","volume":"51","author":"K Pathmanathan","year":"2021","unstructured":"Pathmanathan K, Robinson PC, Hill CL, Keen HI. The prevalence of gout and hyperuricaemia in Australia: An updated systematic review. Semin Arthritis Rheum. 2021;51(1):121\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"8180_CR29","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1002\/art.41404","volume":"72","author":"S Safiri","year":"2020","unstructured":"Safiri S, Kolahi AA, Cross M, Carson-Chahhoud K, Hoy D, Almasi-Hashiani A, et al. Prevalence, Incidence, and Years Lived With Disability Due to Gout and Its Attributable Risk Factors for 195 Countries and Territories 1990\u20132017: A Systematic Analysis of the Global Burden of Disease Study 2017. Arthritis Rheumatol. 2020;72(11):1916\u201327.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"8180_CR30","doi-asserted-by":"publisher","DOI":"10.2196\/45943","volume":"9","author":"Q He","year":"2023","unstructured":"He Q, Mok T-N, Sin T-H, Yin J, Li S, Yin Y, et al. Global, regional, and national prevalence of gout from 1990 to 2019: age-period-cohort analysis with future burden prediction. JMIR Public Health Surveill. 2023;9(1): e45943.","journal-title":"JMIR Public Health Surveill"},{"issue":"10","key":"8180_CR31","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008. Arthritis Rheum. 2011;63(10):3136\u201341.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8180_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","volume":"74","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74(4):661\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8180_CR33","first-page":"1582","volume":"31","author":"KL Wallace","year":"2004","unstructured":"Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004;31(8):1582\u20137.","journal-title":"J Rheumatol"},{"key":"8180_CR34","doi-asserted-by":"crossref","unstructured":"Amiri F, Kolahi A-A, Nejadghaderi SA, Noori M, Khabazi A, Sullman M, et al. The burden of gout and its attributable risk factors in the Middle East and North Africa region, 1990\u20132019. The Journal of Rheumatology. 2022:jrheum.220425.","DOI":"10.3899\/jrheum.220425"},{"issue":"4","key":"8180_CR35","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10067-019-04868-9","volume":"39","author":"C Mattiuzzi","year":"2020","unstructured":"Mattiuzzi C, Lippi G. Recent updates on worldwide gout epidemiology. Clin Rheumatol. 2020;39(4):1061\u20133.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"8180_CR36","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1185\/030079906X112606","volume":"22","author":"RA Brook","year":"2006","unstructured":"Brook RA, Kleinman NL, Patel PA, Melkonian AK, Brizee TJ, Smeeding JE, et al. The economic burden of gout on an employed population. Curr Med Res Opin. 2006;22(7):1381\u20139.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"8180_CR37","first-page":"e46","volume":"5","author":"LM Andrews","year":"2013","unstructured":"Andrews LM, Frech-Tamas F, Yadao AM. Ambulatory resource utilization and cost for gout in United States. Am J Pharm. 2013;5(2):e46\u201354.","journal-title":"Am J Pharm"},{"key":"8180_CR38","doi-asserted-by":"crossref","unstructured":"Card-Gowers J, Retat L, Kumar A, Marder BA, Padnick-Silver L, LaMoreaux B, et al. Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study. Rheumatology and Therapy. 2024.","DOI":"10.1007\/s40744-024-00681-2"},{"issue":"1","key":"8180_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3899\/jrheum.160300","volume":"44","author":"A Fischer","year":"2017","unstructured":"Fischer A, Cloutier M, Goodfield J, Borrelli R, Marvin D, Dziarmaga A. The direct economic burden of gout in an elderly Canadian population. J Rheumatol. 2017;44(1):95\u2013101.","journal-title":"J Rheumatol"},{"issue":"1","key":"8180_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13696998.2018.1532904","volume":"22","author":"NM Flores","year":"2019","unstructured":"Flores NM, Nuevo J, Klein AB, Baumgartner S, Morlock R. The economic burden of uncontrolled gout: how controlling gout reduces cost. J Med Econ. 2019;22(1):1\u20136.","journal-title":"J Med Econ"},{"issue":"4","key":"8180_CR41","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/03007995.2017.1417826","volume":"34","author":"Y-Y Lee","year":"2018","unstructured":"Lee Y-Y, Tang C-H, Chen J-H, Kuo L-N, Ko Y. Evaluation of healthcare costs and utilization for patients with gout: a population-based matched cohort study. Curr Med Res Opin. 2018;34(4):735\u201340.","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"8180_CR42","doi-asserted-by":"publisher","first-page":"A499","DOI":"10.1016\/j.jval.2017.08.570","volume":"20","author":"H Dakin","year":"2017","unstructured":"Dakin H, Wilkins J, Hickey D. The Burden And Cost Of Illness Of Gout In Secondary Care In England. Value in Health. 2017;20(9):A499.","journal-title":"Value in Health"},{"issue":"3","key":"8180_CR43","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.clinthera.2012.01.020","volume":"34","author":"H Park","year":"2012","unstructured":"Park H, Rascati KL, Prasla K, McBayne T. Evaluation of health care costs and utilization patterns for patients with gout. Clin Ther. 2012;34(3):640\u201352.","journal-title":"Clin Ther"},{"issue":"2","key":"8180_CR44","first-page":"164","volume":"14","author":"EQ Wu","year":"2008","unstructured":"Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, et al. Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm. 2008;14(2):164\u201375.","journal-title":"J Manag Care Pharm"},{"issue":"2","key":"8180_CR45","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1089\/pop.2012.0057","volume":"16","author":"W Lynch","year":"2013","unstructured":"Lynch W, Chan W, Kleinman N, Andrews L, Yadao AM. Economic burden of gouty arthritis attacks for employees with frequent and infrequent attacks. Popul Health Manag. 2013;16(2):138\u201345.","journal-title":"Popul Health Manag"},{"issue":"6","key":"8180_CR46","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1097\/MJT.0b013e31820543c5","volume":"19","author":"EQ Wu","year":"2012","unstructured":"Wu EQ, Forsythe A, Gu\u00e9rin A, Andrew PY, Latremouille-Viau D, Tsaneva M. Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy. Am J Ther. 2012;19(6):e157\u201366.","journal-title":"Am J Ther"},{"issue":"11","key":"8180_CR47","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1093\/rheumatology\/kes183","volume":"51","author":"JJ Saseen","year":"2012","unstructured":"Saseen JJ, Agashivala N, Allen RR, Ghushchyan V, Yadao AM, Nair KV. Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks. Rheumatology. 2012;51(11):2004\u201312.","journal-title":"Rheumatology"},{"key":"8180_CR48","doi-asserted-by":"crossref","unstructured":"Rai SK, Burns LC, De Vera MA, Haji A, Giustini D, Choi HK, editors. The economic burden of gout: a systematic review. Seminars in arthritis and rheumatism; 2015: Elsevier.","DOI":"10.1016\/j.semarthrit.2015.02.004"},{"issue":"5","key":"8180_CR49","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3899\/jrheum.080487","volume":"36","author":"EQ Wu","year":"2009","unstructured":"Wu EQ, Patel PA, Mody RR, Yu AP, Cahill KE, Tang J, et al. Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter? J Rheumatol. 2009;36(5):1032\u201340.","journal-title":"J Rheumatol"},{"issue":"26","key":"8180_CR50","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1056\/NEJM197906283002604","volume":"300","author":"GR Boss","year":"1979","unstructured":"Boss GR, Seegmiller JE. Hyperuricemia and gout: classification, complications and management. N Engl J Med. 1979;300(26):1459\u201368.","journal-title":"N Engl J Med"},{"key":"8180_CR51","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3949\/ccjm.75.Suppl_5.S5","volume":"75","author":"BF Mandell","year":"2008","unstructured":"Mandell BF. Clinical manifestations of hyperuricemia and gout. Clevel Clin J Med. 2008;75:S5-8.","journal-title":"Clevel Clin J Med"},{"issue":"23","key":"8180_CR52","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"MA Becker","year":"2005","unstructured":"Becker MA, Schumacher HR, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout. N Engl J Med. 2005;353(23):2450\u201361.","journal-title":"N Engl J Med"},{"issue":"4","key":"8180_CR53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/1759720X16646703","volume":"8","author":"SE Sattui","year":"2016","unstructured":"Sattui SE, Gaffo AL. Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications. Therapeutic Advances in Musculoskeletal Disease. 2016;8(4):145\u201359.","journal-title":"Therapeutic Advances in Musculoskeletal Disease"},{"issue":"5","key":"8180_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jbspin.2020.05.002","volume":"87","author":"T Pascart","year":"2020","unstructured":"Pascart T, Latourte A, Flipo R-M, Chal\u00e8s G, Coblentz-Baumann L, Cohen-Solal A, et al. 2020 recommendations from the French Society of Rheumatology for the management of gout: urate-lowering therapy. Joint Bone Spine. 2020;87(5):395\u2013404.","journal-title":"Joint Bone Spine"},{"key":"8180_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3899\/jrheum.140460","volume":"92","author":"AS Kydd","year":"2014","unstructured":"Kydd AS, Seth R, Buchbinder R, Falzon L, Edwards CJ, van der Heijde DM, et al. Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviews. J Rheumatol Suppl. 2014;92:33\u201341.","journal-title":"J Rheumatol Suppl"},{"issue":"5","key":"8180_CR56","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1681\/ASN.V115974","volume":"11","author":"DM Clive","year":"2000","unstructured":"Clive DM. Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol. 2000;11(5):974\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"8180_CR57","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/art.21499","volume":"54","author":"J Graessler","year":"2006","unstructured":"Graessler J, Graessler A, Unger S, Kopprasch S, Tausche AK, Kuhlisch E, et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum. 2006;54(1):292\u2013300.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8180_CR58","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4081\/reumatismo.2011.238","volume":"63","author":"W Grassi","year":"2012","unstructured":"Grassi W, De Angelis R. Clinical features of gout. Reumatismo. 2012;63(4):238\u201345.","journal-title":"Reumatismo"},{"issue":"7","key":"8180_CR59","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007\u20132008. Am J Med. 2012;125(7):679-87.e1.","journal-title":"Am J Med"},{"key":"8180_CR60","doi-asserted-by":"publisher","first-page":"6358954","DOI":"10.1155\/2020\/6358954","volume":"2020","author":"YJ Fang","year":"2020","unstructured":"Fang YJ, Chung YL, Lin CL, Lim YP. Association between Gout, Urate-Lowering Therapy, and Risk of Developing Type 2 Diabetes Mellitus: A Nationwide Population-Based Retrospective Cohort Study. Biomed Res Int. 2020;2020:6358954.","journal-title":"Biomed Res Int"},{"issue":"1","key":"8180_CR61","doi-asserted-by":"publisher","first-page":"7578","DOI":"10.1038\/s41598-020-64587-z","volume":"10","author":"E Zitt","year":"2020","unstructured":"Zitt E, Fischer A, Lhotta K, Concin H, Nagel G. Sex- and age-specific variations, temporal trends and metabolic determinants of serum uric acid concentrations in a large population-based Austrian cohort. Sci Rep. 2020;10(1):7578.","journal-title":"Sci Rep"},{"key":"8180_CR62","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ypmed.2015.10.003","volume":"81","author":"P W\u00e4ndell","year":"2015","unstructured":"W\u00e4ndell P, Carlsson AC, Ljunggren G. Gout and its comorbidities in the total population of Stockholm. Prev Med. 2015;81:387\u201391.","journal-title":"Prev Med"},{"issue":"2","key":"8180_CR63","first-page":"301","volume":"20","author":"S-Y Chuang","year":"2011","unstructured":"Chuang S-Y, Lee S-C, Hsieh Y-T, Pan W-H. Trends in Hyperuricemia and Gout Prevalence: Nutrition and Health Survey in Taiwan from 1993\u20131996 to 2005\u20132008. Asia Pac J Clin Nutr. 2011;20(2):301\u20138.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"1","key":"8180_CR64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jbspin.2010.02.027","volume":"78","author":"TR Merriman","year":"2011","unstructured":"Merriman TR, Dalbeth N. The genetic basis of hyperuricaemia and gout. Joint Bone Spine. 2011;78(1):35\u201340.","journal-title":"Joint Bone Spine"},{"issue":"11","key":"8180_CR65","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1172\/JCI103966","volume":"38","author":"CA Nugent","year":"1959","unstructured":"Nugent CA, Tyler FH. The renal excretion of uric acid in patients with gout and in nongouty subjects. J Clin Invest. 1959;38(11):1890\u20138.","journal-title":"J Clin Invest"},{"issue":"6","key":"8180_CR66","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/art.10792","volume":"47","author":"F Perez-Ruiz","year":"2002","unstructured":"Perez-Ruiz F, Calabozo M, Erauskin GG, Ruibal A, Herrero-Beites AM. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum. 2002;47(6):610\u20133.","journal-title":"Arthritis Rheum"},{"key":"8180_CR67","doi-asserted-by":"crossref","unstructured":"Major TJ, Topless RK, Dalbeth N, Merriman TR. Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts. Bmj. 2018;363.","DOI":"10.1136\/bmj.k3951"},{"issue":"3","key":"8180_CR68","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/ard.51.3.375","volume":"51","author":"BT Emmerson","year":"1992","unstructured":"Emmerson BT, Nagel SL, Duffy DL, Martin NG. Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis. 1992;51(3):375\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8180_CR69","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/hmg\/ddaa013","volume":"29","author":"J Boocock","year":"2020","unstructured":"Boocock J, Leask M, Okada Y, Matsuo H, Kawamura Y, Shi Y, et al. Genomic dissection of 43 serum urate-associated loci provides multiple insights into molecular mechanisms of urate control. Hum Mol Genet. 2020;29(6):923\u201343.","journal-title":"Hum Mol Genet"},{"key":"8180_CR70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s42003-019-0339-0","volume":"2","author":"M Nakatochi","year":"2019","unstructured":"Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ichihara S, et al. Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals. Commun Biol. 2019;2:115.","journal-title":"Commun Biol"},{"issue":"6","key":"8180_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000504","volume":"5","author":"M Kolz","year":"2009","unstructured":"Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 2009;5(6): e1000504.","journal-title":"PLoS Genet"},{"key":"8180_CR72","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ncomms1756","volume":"3","author":"K Ichida","year":"2012","unstructured":"Ichida K, Matsuo H, Takada T, Nakayama A, Murakami K, Shimizu T, et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun. 2012;3:764.","journal-title":"Nat Commun"},{"issue":"4","key":"8180_CR73","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/annrheumdis-2017-212416","volume":"77","author":"AL Gosling","year":"2018","unstructured":"Gosling AL, Boocock J, Dalbeth N, Harr\u00e9 Hindmarsh J, Stamp LK, Stahl EA, et al. Mitochondrial genetic variation and gout in M\u0101ori and Pacific people living in Aotearoa New Zealand. Ann Rheum Dis. 2018;77(4):571\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8180_CR74","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ng.106","volume":"40","author":"V Vitart","year":"2008","unstructured":"Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008;40(4):437\u201342.","journal-title":"Nat Genet"},{"issue":"4","key":"8180_CR75","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ng.107","volume":"40","author":"A D\u00f6ring","year":"2008","unstructured":"D\u00f6ring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet. 2008;40(4):430\u20136.","journal-title":"Nat Genet"},{"issue":"1","key":"8180_CR76","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ajhg.2007.11.001","volume":"82","author":"C Wallace","year":"2008","unstructured":"Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, Falchi M, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet. 2008;82(1):139\u201349.","journal-title":"Am J Hum Genet"},{"issue":"9654","key":"8180_CR77","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","volume":"372","author":"A Dehghan","year":"2008","unstructured":"Dehghan A, K\u00f6ttgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372(9654):1953\u201361.","journal-title":"Lancet"},{"issue":"4","key":"8180_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001948","volume":"3","author":"K Stark","year":"2008","unstructured":"Stark K, Reinhard W, Neureuther K, Wiedmann S, Sedlacek K, Baessler A, et al. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. PLoS ONE. 2008;3(4): e1948.","journal-title":"PLoS ONE"},{"issue":"6887","key":"8180_CR79","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature742","volume":"417","author":"A Enomoto","year":"2002","unstructured":"Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature. 2002;417(6887):447\u201352.","journal-title":"Nature"},{"issue":"23","key":"8180_CR80","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.lfs.2006.07.030","volume":"79","author":"Y Shima","year":"2006","unstructured":"Shima Y, Teruya K, Ohta H. Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci. 2006;79(23):2234\u20137.","journal-title":"Life Sci"},{"issue":"2","key":"8180_CR81","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/rheumatology\/kel205","volume":"46","author":"J V\u00e1zquez-Mellado","year":"2007","unstructured":"V\u00e1zquez-Mellado J, Jim\u00e9nez-Vaca AL, Cuevas-Covarrubias S, Alvarado-Romano V, Pozo-Molina G, Burgos-Vargas R. Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford). 2007;46(2):215\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"8180_CR82","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1093\/rheumatology\/keq274","volume":"49","author":"HH Dao","year":"2010","unstructured":"Dao HH, Harun-Or-Rashid M, Sakamoto J. Body composition and metabolic syndrome in patients with primary gout in Vietnam. Rheumatology (Oxford). 2010;49(12):2400\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"8180_CR83","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/03009740802572483","volume":"38","author":"M Guan","year":"2009","unstructured":"Guan M, Zhang J, Chen Y, Liu W, Kong N, Zou H. High-resolution melting analysis for the rapid detection of an intronic single nucleotide polymorphism in SLC22A12 in male patients with primary gout in China. Scand J Rheumatol. 2009;38(4):276\u201381.","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"8180_CR84","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/rheumatology\/keq096","volume":"49","author":"K Yamagishi","year":"2010","unstructured":"Yamagishi K, Tanigawa T, Kitamura A, K\u00f6ttgen A, Folsom AR, Iso H. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people. Rheumatology (Oxford). 2010;49(8):1461\u20135.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"8180_CR85","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pcd.2020.06.002","volume":"14","author":"YC Tung","year":"2020","unstructured":"Tung YC, Lee MY, Wang YC, Chang CJ, Tsai WC, Lin GT, et al. Effect modification of hyperlipidemia and hypertension on the association between type 2 diabetes and gout. Prim Care Diabetes. 2020;14(6):654\u201362.","journal-title":"Prim Care Diabetes"},{"issue":"24","key":"8180_CR86","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1093\/hmg\/ddq412","volume":"19","author":"AJ Phipps-Green","year":"2010","unstructured":"Phipps-Green AJ, Hollis-Moffatt JE, Dalbeth N, Merriman ME, Topless R, Gow PJ, et al. A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not M\u0101ori, case and control sample sets. Hum Mol Genet. 2010;19(24):4813\u20139.","journal-title":"Hum Mol Genet"},{"issue":"25","key":"8180_CR87","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1073\/pnas.0901249106","volume":"106","author":"OM Woodward","year":"2009","unstructured":"Woodward OM, K\u00f6ttgen A, Coresh J, Boerwinkle E, Guggino WB, K\u00f6ttgen M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci. 2009;106(25):10338\u201342.","journal-title":"Proc Natl Acad Sci"},{"key":"8180_CR88","doi-asserted-by":"crossref","unstructured":"Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, Ikebuchi Y, et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Science translational medicine. 2009;1(5):5ra11\u20135ra.","DOI":"10.1126\/scitranslmed.3000237"},{"issue":"2","key":"8180_CR89","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ng.2500","volume":"45","author":"A K\u00f6ttgen","year":"2013","unstructured":"K\u00f6ttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45(2):145\u201354.","journal-title":"Nat Genet"},{"issue":"2","key":"8180_CR90","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/BOR.0b013e328032781a","volume":"19","author":"N Anzai","year":"2007","unstructured":"Anzai N, Kanai Y, Endou H. New insights into renal transport of urate. Curr Opin Rheumatol. 2007;19(2):151\u20137.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"8180_CR91","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/hmg\/ddp489","volume":"19","author":"P van der Harst","year":"2010","unstructured":"van der Harst P, Bakker SJ, de Boer RA, Wolffenbuttel BH, Johnson T, Caulfield MJ, et al. Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet. 2010;19(2):387\u201395.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"8180_CR92","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/ard.2008.106856","volume":"69","author":"W Urano","year":"2010","unstructured":"Urano W, Taniguchi A, Anzai N, Inoue E, Kanai Y, Yamanaka M, et al. Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann Rheum Dis. 2010;69(6):1232\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"8180_CR93","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3899\/jrheum.150310","volume":"42","author":"PC Robinson","year":"2015","unstructured":"Robinson PC, Taylor WJ, Dalbeth N. An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population. J Rheumatol. 2015;42(9):1702\u20137.","journal-title":"J Rheumatol"},{"issue":"1","key":"8180_CR94","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000166","volume":"2","author":"JC Branco","year":"2016","unstructured":"Branco JC, Rodrigues AM, Gouveia N, Eus\u00e9bio M, Ramiro S, Machado PM, et al. Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey. RMD Open. 2016;2(1): e000166.","journal-title":"RMD Open"},{"key":"8180_CR95","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13075-016-1062-6","volume":"18","author":"M Dehlin","year":"2016","unstructured":"Dehlin M, Drivelegka P, Sigurdardottir V, Sv\u00e4rd A, Jacobsson LT. Incidence and prevalence of gout in Western Sweden. Arthritis Res Ther. 2016;18:164.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"8180_CR96","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1053\/j.ajkd.2017.01.053","volume":"70","author":"S Kim","year":"2017","unstructured":"Kim S, Chang Y, Yun KE, Jung H-S, Lee S-J, Shin H, et al. Development of nephrolithiasis in asymptomatic hyperuricemia: a cohort study. Am J Kidney Dis. 2017;70(2):173\u201381.","journal-title":"Am J Kidney Dis"},{"issue":"47","key":"8180_CR97","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005425","volume":"95","author":"B Zhang","year":"2016","unstructured":"Zhang B, Fang W, Zeng X, Zhang Y, Ma Y, Sheng F, et al. Clinical characteristics of early- and late-onset gout: A cross-sectional observational study from a Chinese gout clinic. Medicine (Baltimore). 2016;95(47): e5425.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"8180_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar3272","volume":"13","author":"L Cea Soriano","year":"2011","unstructured":"Cea Soriano L, Rothenbacher D, Choi HK, Garc\u00eda Rodr\u00edguez LA. Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther. 2011;13(2):1\u20139.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"8180_CR99","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/ard.32.4.386","volume":"32","author":"A Nicholls","year":"1973","unstructured":"Nicholls A, Snaith ML, Yablonsky H, Scott JT. Effect of stilboestrol on levels of uric acid in plasma and urine. Ann Rheum Dis. 1973;32(4):386\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"8180_CR100","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/ard.2009.109884","volume":"69","author":"AE Hak","year":"2010","unstructured":"Hak AE, Curhan GC, Grodstein F, Choi HK. Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis. 2010;69(7):1305\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"8180_CR101","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/rheumatology\/ker361","volume":"51","author":"D Winnard","year":"2012","unstructured":"Winnard D, Wright C, Taylor WJ, Jackson G, Te Karu L, Gow PJ, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford). 2012;51(5):901\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"8180_CR102","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11926-012-0307-x","volume":"15","author":"JA Singh","year":"2013","unstructured":"Singh JA. Racial and gender disparities among patients with gout. Curr Rheumatol Rep. 2013;15(2):307.","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"8180_CR103","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/acr.20232","volume":"62","author":"AJ Portis","year":"2010","unstructured":"Portis AJ, Laliberte M, Tatman P, Moua M, Culhane-Pera K, Maalouf NM, et al. High prevalence of gouty arthritis among the Hmong population in Minnesota. Arthritis Care Res (Hoboken). 2010;62(10):1386\u201391.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"8180_CR104","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3109\/rhe1.1969.15.issue-1-4.17","volume":"15","author":"HA Isom\u00e4ki","year":"1969","unstructured":"Isom\u00e4ki HA, Takkunen H. Gout and hyperuricemia in a Finnish rural population. Acta Rheumatol Scand. 1969;15(2):112\u201320.","journal-title":"Acta Rheumatol Scand"},{"issue":"2","key":"8180_CR105","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/ard.21.2.154","volume":"21","author":"AJ Popert","year":"1962","unstructured":"Popert AJ, Hewitt JV. Gout and hyperuricaemia in rural and urban populations. Ann Rheum Dis. 1962;21(2):154\u201363.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8180_CR106","first-page":"302","volume":"21","author":"CT Chou","year":"1994","unstructured":"Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol. 1994;21(2):302\u20136.","journal-title":"J Rheumatol"},{"issue":"7","key":"8180_CR107","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/acr.23926","volume":"72","author":"A Chiou","year":"2020","unstructured":"Chiou A, England BR, Sayles H, Thiele GM, Duryee MJ, Baker JF, et al. Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality. Arthritis Care Res (Hoboken). 2020;72(7):950\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"8180_CR108","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","volume":"41","author":"RC Lawrence","year":"1998","unstructured":"Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 1998;41(5):778\u201399.","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"7","key":"8180_CR109","first-page":"1350","volume":"29","author":"AG Fam","year":"2002","unstructured":"Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol. 2002;29(7):1350\u20135.","journal-title":"J Rheumatol"},{"issue":"6","key":"8180_CR110","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.ackd.2012.07.011","volume":"19","author":"E Kedar","year":"2012","unstructured":"Kedar E, Simkin PA. A perspective on diet and gout. Adv Chronic Kidney Dis. 2012;19(6):392\u20137.","journal-title":"Adv Chronic Kidney Dis"},{"key":"8180_CR111","doi-asserted-by":"crossref","unstructured":"Kaneko K, Aoyagi Y, Fukuuchi T, Inazawa K, Yamaoka N. Total purine and purine base content of common foodstuffs for facilitating nutritional therapy for gout and hyperuricemia. Biological and Pharmaceutical Bulletin. 2014:b13\u201300967.","DOI":"10.1248\/bpb.b13-00967"},{"issue":"11","key":"8180_CR112","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.amjmed.2016.06.040","volume":"129","author":"RN Beyl Jr","year":"2016","unstructured":"Beyl RN Jr, Hughes L, Morgan S. Update on Importance of Diet in Gout. Am J Med. 2016;129(11):1153\u20138.","journal-title":"Am J Med"},{"issue":"8","key":"8180_CR113","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.ejcn.1602615","volume":"61","author":"S Haldar","year":"2007","unstructured":"Haldar S, Rowland I, Barnett Y, Bradbury I, Robson P, Powell J, et al. Influence of habitual diet on antioxidant status: a study in a population of vegetarians and omnivores. Eur J Clin Nutr. 2007;61(8):1011\u201322.","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"8180_CR114","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/annrheumdis-2011-201254","volume":"72","author":"G Trifir\u00f2","year":"2013","unstructured":"Trifir\u00f2 G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005\u20132009: a nationwide population-based study. Ann Rheum Dis. 2013;72(5):694\u2013700.","journal-title":"Ann Rheum Dis"},{"issue":"26","key":"8180_CR115","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1056\/NEJM198212233072602","volume":"307","author":"J Faller","year":"1982","unstructured":"Faller J, Fox IH. Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover. N Engl J Med. 1982;307(26):1598\u2013602.","journal-title":"N Engl J Med"},{"issue":"3","key":"8180_CR116","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/rheumatology\/23.3.203","volume":"23","author":"T Gibson","year":"1984","unstructured":"Gibson T, Rodgers A, Simmonds H, Toseland P. Beer drinking and its effect on uric acid. Rheumatology. 1984;23(3):203\u20139.","journal-title":"Rheumatology"},{"issue":"9417","key":"8180_CR117","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","volume":"363","author":"HK Choi","year":"2004","unstructured":"Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. The Lancet. 2004;363(9417):1277\u201381.","journal-title":"The Lancet"},{"issue":"6","key":"8180_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038123","volume":"7","author":"L Zgaga","year":"2012","unstructured":"Zgaga L, Theodoratou E, Kyle J, Farrington SM, Agakov F, Tenesa A, et al. The association of dietary intake of purine-rich vegetables, sugar-sweetened beverages and dairy with plasma urate, in a cross-sectional study. PLoS ONE. 2012;7(6): e38123.","journal-title":"PLoS ONE"},{"issue":"6","key":"8180_CR119","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/art.22712","volume":"56","author":"HK Choi","year":"2007","unstructured":"Choi HK, Willett W, Curhan G. Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum. 2007;56(6):2049\u201355.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"8180_CR120","first-page":"1853","volume":"35","author":"X Gao","year":"2008","unstructured":"Gao X, Curhan G, Forman JP, Ascherio A, Choi HK. Vitamin C intake and serum uric acid concentration in men. J Rheumatol. 2008;35(9):1853\u20138.","journal-title":"J Rheumatol"},{"key":"8180_CR121","doi-asserted-by":"crossref","unstructured":"Kim JH, Choi IA, Kim A, Kang G. Clinical Association between Gout and Parkinson's Disease: A Nationwide Population-Based Cohort Study in Korea. Medicina (Kaunas). 2021;57(12).","DOI":"10.3390\/medicina57121292"},{"issue":"7","key":"8180_CR122","first-page":"1341","volume":"33","author":"DJ Hunter","year":"2006","unstructured":"Hunter DJ, York M, Chaisson CE, Woods R, Niu J, Zhang Y. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study. J Rheumatol. 2006;33(7):1341\u20135.","journal-title":"J Rheumatol"},{"issue":"7","key":"8180_CR123","first-page":"24","volume":"60","author":"D Ene-Stroescu","year":"2005","unstructured":"Ene-Stroescu D, Gorbien MJ. Gouty arthritis. A primer on late-onset gout Geriatrics. 2005;60(7):24\u201331.","journal-title":"A primer on late-onset gout Geriatrics"},{"key":"8180_CR124","doi-asserted-by":"crossref","unstructured":"Dubreuil M, Neogi T, Chen CA, Choi HK, Chaisson CE, Hunter DJ, et al. Increased risk of recurrent gout attacks with hospitalization. The American journal of medicine. 2013;126(12):1138\u201341. e1.","DOI":"10.1016\/j.amjmed.2013.06.026"},{"key":"8180_CR125","unstructured":"Suppiah R, Dissanayake A, Dalbeth N. High prevalence of gout in patients with Type 2 diabetes: male sex, renal impairment, and diuretic use are major risk factors. The New Zealand Medical Journal (Online). 2008;121(1283)."},{"issue":"1","key":"8180_CR126","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/art.38203","volume":"66","author":"S Bruderer","year":"2014","unstructured":"Bruderer S, Bodmer M, Jick SS, Meier CR. Use of Diuretics and Risk of Incident Gout: A Population-Based Case-Control Study. Arthritis & rheumatology. 2014;66(1):185\u201396.","journal-title":"Arthritis & rheumatology"},{"key":"8180_CR127","doi-asserted-by":"crossref","unstructured":"Choi HK, Soriano LC, Zhang Y, Rodr\u00edguez LAG. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. Bmj. 2012;344.","DOI":"10.1136\/bmj.d8190"},{"issue":"4","key":"8180_CR128","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/art.27338","volume":"62","author":"V Bhole","year":"2010","unstructured":"Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H. Epidemiology of gout in women: Fifty-two\u2013year followup of a prospective cohort. Arthritis Rheum. 2010;62(4):1069\u201376.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8180_CR129","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0895-4356(97)00101-7","volume":"50","author":"JH Gurwitz","year":"1997","unstructured":"Gurwitz JH, Kalish SC, Bohn RL, Glynn RJ, Monane M, Mogun H, et al. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol. 1997;50(8):953\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"8180_CR130","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1023\/B:CARD.0000015855.02485.e3","volume":"17","author":"AJ Reyes","year":"2003","unstructured":"Reyes AJ. Cardiovascular drugs and serum uric acid. Cardiovasc Drugs Ther. 2003;17(5):397\u2013414.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"8180_CR131","first-page":"362","volume":"16","author":"S Creighton","year":"2005","unstructured":"Creighton S, Miller R, Edwards S, Copas A, French P. Is ritonavir boosting associated with gout? Int J STD AIDS. 2005;16(5):362\u20134.","journal-title":"Int J STD AIDS"},{"issue":"11","key":"8180_CR132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007729","volume":"4","author":"K Stark","year":"2009","unstructured":"Stark K, Reinhard W, Grassl M, Erdmann J, Schunkert H, Illig T, et al. Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLoS ONE. 2009;4(11): e7729.","journal-title":"PLoS ONE"},{"issue":"3","key":"8180_CR133","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00002281-200105000-00016","volume":"13","author":"N Schlesinger","year":"2001","unstructured":"Schlesinger N, Schumacher HR Jr. Gout: can management be improved? Curr Opin Rheumatol. 2001;13(3):240\u20134.","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"8180_CR134","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/JCI103905","volume":"38","author":"AB Gutman","year":"1959","unstructured":"Gutman AB. Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Investig. 1959;38(8):1298\u2013315.","journal-title":"J Clin Investig"},{"issue":"1","key":"8180_CR135","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/annrheumdis-2014-205827","volume":"75","author":"YH Rho","year":"2016","unstructured":"Rho YH, Lu N, Peloquin CE, Man A, Zhu Y, Zhang Y, et al. Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study. Ann Rheum Dis. 2016;75(1):91\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8180_CR136","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1177\/106002809002401119","volume":"24","author":"MI Amodio","year":"1990","unstructured":"Amodio MI, Bengualid V, Lowy FD. Development of acute gout secondary to pyrazinamide in a patient without a prior history of gout. DICP. 1990;24(11):1115\u20136.","journal-title":"DICP"},{"key":"8180_CR137","first-page":"271","volume":"123","author":"T Rao","year":"1996","unstructured":"Rao T. Gout secondary to pyrazinamide and ethambutol. Va Med Q. 1996;123:271.","journal-title":"Va Med Q"},{"issue":"2","key":"8180_CR138","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/152692480401400208","volume":"14","author":"S Baroletti","year":"2004","unstructured":"Baroletti S, Bencivenga GA, Gabardi S. Treating gout in kidney transplant recipients. Prog Transplant. 2004;14(2):143\u20137.","journal-title":"Prog Transplant"},{"key":"8180_CR139","doi-asserted-by":"crossref","unstructured":"Brigham MD, Radeck LP, Mendonca CM, Lang I, Li JW, Kent JD, et al., editors. Gout severity in recipients of kidney transplant. Transplantation Proceedings; 2019: Elsevier.","DOI":"10.1016\/j.transproceed.2019.04.050"},{"issue":"11","key":"8180_CR140","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1097\/TP.0b013e31818b22ed","volume":"86","author":"G Hern\u00e1ndez-Molina","year":"2008","unstructured":"Hern\u00e1ndez-Molina G, Cachafeiro-Vilar A, Villa AR, Alber\u00fa J, Rull-Gabayet M. Gout in renal allograft recipients according to the pretransplant hyperuricemic status. Transplantation. 2008;86(11):1543\u20137.","journal-title":"Transplantation"},{"issue":"3","key":"8180_CR141","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11906-001-0038-2","volume":"3","author":"LM Ruilope","year":"2001","unstructured":"Ruilope LM, Garcia-Puig J. Hyperuricemia and renal function. Curr Hypertens Rep. 2001;3(3):197\u2013202.","journal-title":"Curr Hypertens Rep"},{"key":"8180_CR142","unstructured":"Delaney V, Sumrani N, DASKALKIS P, Hong J, Sommer B, editors. Hyperucemia and gout in renal allograft recipients. Transplantation proceedings; 1992."},{"issue":"10","key":"8180_CR143","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/01.tp.0000188722.84775.af","volume":"80","author":"KC Abbott","year":"2005","unstructured":"Abbott KC, Kimmel PL, Dharnidharka V, Oglesby RJ, Agodoa LY, Caillard S. New-onset gout after kidney transplantation: incidence, risk factors and implications. Transplantation. 2005;80(10):1383\u201391.","journal-title":"Transplantation"},{"issue":"3","key":"8180_CR144","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000188609","volume":"70","author":"R Marcen","year":"1995","unstructured":"Marcen R, Gallego N, Orofino L, Gamez C, Estepa M, Sabater J, et al. Impairment of tubular secretion of urate in renal transplant patients on cyclosporine. Nephron. 1995;70(3):307\u201313.","journal-title":"Nephron"},{"key":"8180_CR145","doi-asserted-by":"crossref","unstructured":"Mazzali M, editor Uric acid and transplantation. Seminars in nephrology; 2005: Elsevier.","DOI":"10.1016\/j.semnephrol.2004.09.008"},{"issue":"4","key":"8180_CR146","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1159\/000045219","volume":"80","author":"JM Hansen","year":"1998","unstructured":"Hansen JM, Fogh-Andersen N, Leyssac PP, Strandgaard S. Glomerular and tubular function in renal transplant patients treated with and without ciclosporin A. Nephron. 1998;80(4):450\u20137.","journal-title":"Nephron"},{"issue":"3","key":"8180_CR147","doi-asserted-by":"publisher","first-page":"263","DOI":"10.7182\/pit2015322","volume":"25","author":"PM Sullivan","year":"2015","unstructured":"Sullivan PM, William A, Tichy EM. Hyperuricemia and gout in solid-organ transplant: update in pharmacological management. Prog Transplant. 2015;25(3):263\u201370.","journal-title":"Prog Transplant"},{"issue":"9","key":"8180_CR148","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1111\/j.1600-6143.2011.03613.x","volume":"11","author":"A Haririan","year":"2011","unstructured":"Haririan A, Metireddy M, Cangro C, Nogueira J, Rasetto F, Cooper M, et al. Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis. Am J Transplant. 2011;11(9):1943\u201350.","journal-title":"Am J Transplant"},{"key":"8180_CR149","doi-asserted-by":"crossref","unstructured":"Kanbay M, Akcay A, Huddam B, Usluogullari C, Arat Z, Ozdemir F, et al., editors. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Transplantation proceedings; 2005: Elsevier.","DOI":"10.1016\/j.transproceed.2005.08.042"},{"issue":"2","key":"8180_CR150","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0002-9343(92)90104-J","volume":"92","author":"DA Burack","year":"1992","unstructured":"Burack DA, Griffith BP, Thompson ME, Kahl LE. Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med. 1992;92(2):141\u20136.","journal-title":"Am J Med"},{"issue":"3","key":"8180_CR151","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0002-9343(89)80153-6","volume":"87","author":"LE Kahl","year":"1989","unstructured":"Kahl LE, Thompson ME, Griffith BP. Gout in the heart transplant recipient: physiologic puzzle and therapeutic challenge. Am J Med. 1989;87(3):289\u201394.","journal-title":"Am J Med"},{"issue":"15 Suppl","key":"8180_CR152","first-page":"S435","volume":"11","author":"AJ Luk","year":"2005","unstructured":"Luk AJ, Simkin PA. Epidemiology of hyperuricemia and gout. Am J Manag Care. 2005;11(15 Suppl):S435\u201342.","journal-title":"Am J Manag Care"},{"issue":"1","key":"8180_CR153","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0272-6386(87)80156-7","volume":"9","author":"A Greenberg","year":"1987","unstructured":"Greenberg A, Egel JW, Thompson ME, Hardesty RL, Griffith BP, Bahnson HT, et al. Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients. Am J Kidney Dis. 1987;9(1):12\u201322.","journal-title":"Am J Kidney Dis"},{"key":"8180_CR154","unstructured":"Ahn K, Kim Y, Lee H, Park K, Huh K, editors. Cyclosporine-induced hyperuricemia after renal transplant: clinical characteristics and mechanisms. Transplantation proceedings; 1992."},{"issue":"1","key":"8180_CR155","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00007890-199107000-00013","volume":"52","author":"T Noordzij","year":"1991","unstructured":"Noordzij T, Leunissen K, Van Hooff JP. Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use. Transplantation. 1991;52(1):64\u20137.","journal-title":"Transplantation"},{"key":"8180_CR156","doi-asserted-by":"crossref","unstructured":"Braun W, Richmond B, Protiva D, Gifford R, Straffon R, editors. The incidence and management of osteoporosis, gout, and avascular necrosis in recipients of renal allografts functioning more than 20 years (level 5A) treated with prednisone and azathioprine. Transplantation proceedings; 1999.","DOI":"10.1097\/00007890-199805131-00284"},{"issue":"5","key":"8180_CR157","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0272-6386(87)80103-8","volume":"10","author":"C West","year":"1987","unstructured":"West C, Carpenter BJ, Hakala TR. The incidence of gout in renal transplant recipients. Am J Kidney Dis. 1987;10(5):369\u201372.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"8180_CR158","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1097\/00007890-200111270-00021","volume":"72","author":"DA Neal","year":"2001","unstructured":"Neal DA, Tom BD, Gimson AE, Gibbs P, Alexander GJ. Hyperuricemia, gout, and renal function after liver transplantation. Transplantation. 2001;72(10):1689\u201391.","journal-title":"Transplantation"},{"issue":"11","key":"8180_CR159","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1001\/jamainternmed.2018.4463","volume":"178","author":"AB Vargas-Santos","year":"2018","unstructured":"Vargas-Santos AB, Peloquin CE, Zhang Y, Neogi T. Association of chronic kidney disease with allopurinol use in gout treatment. JAMA Intern Med. 2018;178(11):1526\u201333.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"8180_CR160","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/TP.0b013e3181c73c18","volume":"89","author":"A Haririan","year":"2010","unstructured":"Haririan A, Noguiera JM, Zandi-Nejad K, Aiyer R, Hurley H, Cooper M, et al. The independent association between serum uric acid and graft outcomes after kidney transplantation. Transplantation. 2010;89(5):573\u20139.","journal-title":"Transplantation"},{"issue":"1","key":"8180_CR161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-018-1612-1","volume":"20","author":"PL Evans","year":"2018","unstructured":"Evans PL, Prior JA, Belcher J, Mallen CD, Hay CA, Roddy E. Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies. Arthritis Res Ther. 2018;20(1):1\u201315.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"8180_CR162","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/rheumatology\/key229","volume":"57","author":"SC Larsson","year":"2018","unstructured":"Larsson SC, Burgess S, Micha\u00eblsson K. Genetic association between adiposity and gout: a Mendelian randomization study. Rheumatology. 2018;57(12):2145\u20138.","journal-title":"Rheumatology"},{"issue":"4","key":"8180_CR163","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3899\/jrheum.170806","volume":"45","author":"MM Elfishawi","year":"2018","unstructured":"Elfishawi MM, Zleik N, Kvrgic Z, Michet CJ, Crowson CS, Matteson EL, et al. The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years. J Rheumatol. 2018;45(4):574\u20139.","journal-title":"J Rheumatol"},{"issue":"4","key":"8180_CR164","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/annrheumdis-2016-209958","volume":"76","author":"C Maglio","year":"2017","unstructured":"Maglio C, Peltonen M, Neovius M, Jacobson P, Jacobsson L, Rudin A, et al. Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial. Ann Rheum Dis. 2017;76(4):688\u201393.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8180_CR165","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/BOR.0000000000000691","volume":"32","author":"NA Sumpter","year":"2020","unstructured":"Sumpter NA, Saag KG, Reynolds RJ, Merriman TR. Comorbidities in gout and hyperuricemia: causality or epiphenomena? Curr Opin Rheumatol. 2020;32(2):126\u201333.","journal-title":"Curr Opin Rheumatol"},{"issue":"1089","key":"8180_CR166","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/postgradmedj-2015-133691","volume":"92","author":"A Collier","year":"2016","unstructured":"Collier A, Stirling A, Cameron L, Hair M, Crosbie D. Gout and diabetes: a common combination. Postgrad Med J. 2016;92(1089):372\u20138.","journal-title":"Postgrad Med J"},{"issue":"1","key":"8180_CR167","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/annrheumdis-2013-203779","volume":"74","author":"P Richette","year":"2015","unstructured":"Richette P, Clerson P, P\u00e9rissin L, Flipo RM, Bardin T. Revisiting comorbidities in gout: a cluster analysis. Ann Rheum Dis. 2015;74(1):142\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8180_CR168","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1097\/HJH.0b013e32830e4945","volume":"26","author":"P Men\u00e8","year":"2008","unstructured":"Men\u00e8 P, Punzo G. Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens. 2008;26(11):2085\u201392.","journal-title":"J Hypertens"},{"issue":"1","key":"8180_CR169","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/acr.20344","volume":"63","author":"PC Grayson","year":"2011","unstructured":"Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63(1):102\u201310.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8180_CR170","doi-asserted-by":"crossref","unstructured":"Johnson RJ, Kang D-H, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? hypertension. 2003;41(6):1183\u201390.","DOI":"10.1161\/01.HYP.0000069700.62727.C5"},{"issue":"5","key":"8180_CR171","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"UM Khosla","year":"2005","unstructured":"Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67(5):1739\u201342.","journal-title":"Kidney Int"},{"issue":"22","key":"8180_CR172","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1161\/01.CIR.0000017502.58595.ED","volume":"105","author":"W Doehner","year":"2002","unstructured":"Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation. 2002;105(22):2619\u201324.","journal-title":"Circulation"},{"issue":"13","key":"8180_CR173","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.1016\/S0021-9258(18)93017-6","volume":"266","author":"GN Rao","year":"1991","unstructured":"Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem. 1991;266(13):8604\u20138.","journal-title":"J Biol Chem"},{"issue":"4","key":"8180_CR174","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/j.1523-1755.2004.00909.x","volume":"66","author":"TS Perlstein","year":"2004","unstructured":"Perlstein TS, Gumieniak O, Hopkins PN, Murphey LJ, Brown NJ, Williams GH, et al. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int. 2004;66(4):1465\u201370.","journal-title":"Kidney Int"},{"issue":"1","key":"8180_CR175","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000282","volume":"2","author":"E Krishnan","year":"2012","unstructured":"Krishnan E. Gout and the risk for incident heart failure and systolic dysfunction. BMJ Open. 2012;2(1): e000282.","journal-title":"BMJ Open"},{"issue":"4","key":"8180_CR176","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/rheumatology\/kev418","volume":"55","author":"C-F Kuo","year":"2016","unstructured":"Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M. Impact of gout on the risk of atrial fibrillation. Rheumatology. 2016;55(4):721\u20138.","journal-title":"Rheumatology"},{"key":"8180_CR177","doi-asserted-by":"crossref","unstructured":"Chang K, Yokose C, Tenner C, Oh C, Donnino R, Choy-Shan A, et al. Association between gout and aortic stenosis. The American journal of medicine. 2017;130(2):230. e1-. e8.","DOI":"10.1016\/j.amjmed.2016.09.005"},{"issue":"4","key":"8180_CR178","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/annrheumdis-2014-205252","volume":"74","author":"LE Clarson","year":"2015","unstructured":"Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis. 2015;74(4):642\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8180_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41927-019-0060-0","volume":"3","author":"DH Jaffe","year":"2019","unstructured":"Jaffe DH, Klein AB, Benis A, Flores NM, Gabay H, Morlock R, et al. Incident gout and chronic Kidney Disease: healthcare utilization and survival. BMC rheumatology. 2019;3(1):1\u201311.","journal-title":"BMC rheumatology"},{"issue":"8","key":"8180_CR180","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1002\/art.22014","volume":"54","author":"E Krishnan","year":"2006","unstructured":"Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2006;54(8):2688\u201396.","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"1","key":"8180_CR181","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","volume":"15","author":"T Bardin","year":"2017","unstructured":"Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017;15(1):123.","journal-title":"BMC Med"},{"issue":"10","key":"8180_CR182","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/jamacardio.2019.3201","volume":"4","author":"AS Klauser","year":"2019","unstructured":"Klauser AS, Halpern EJ, Strobl S, Gruber J, Feuchtner G, Bellmann-Weiler R, et al. Dual-energy computed tomography detection of cardiovascular monosodium urate deposits in patients with gout. JAMA cardiology. 2019;4(10):1019\u201328.","journal-title":"JAMA cardiology"},{"issue":"2","key":"8180_CR183","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/BOR.0000000000000028","volume":"26","author":"T Bardin","year":"2014","unstructured":"Bardin T, Richette P. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol. 2014;26(2):186\u201391.","journal-title":"Curr Opin Rheumatol"},{"key":"8180_CR184","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.phrs.2018.01.009","volume":"133","author":"G Medina","year":"2018","unstructured":"Medina G, Vera-Lastra O, Peralta-Amaro AL, Jim\u00e9nez-Arellano MP, Saavedra MA, Cruz-Dom\u00ednguez MP, et al. Metabolic syndrome, autoimmunity and rheumatic diseases. Pharmacol Res. 2018;133:277\u201388.","journal-title":"Pharmacol Res"},{"issue":"4","key":"8180_CR185","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3904\/kjim.2016.062","volume":"33","author":"JH Jung","year":"2018","unstructured":"Jung JH, Song GG, Ji JD, Lee YH, Kim JH, Seo YH, et al. Metabolic syndrome: prevalence and risk factors in Korean gout patients. Korean J Intern Med. 2018;33(4):815\u201322.","journal-title":"Korean J Intern Med"},{"issue":"10","key":"8180_CR186","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11926-017-0688-y","volume":"19","author":"GE Thottam","year":"2017","unstructured":"Thottam GE, Krasnokutsky S, Pillinger MH. Gout and Metabolic Syndrome: a Tangled Web. Curr Rheumatol Rep. 2017;19(10):60.","journal-title":"Curr Rheumatol Rep"},{"key":"8180_CR187","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.006","volume":"80","author":"C Borghi","year":"2020","unstructured":"Borghi C, Agabiti-Rosei E, Johnson RJ, Kielstein JT, Lurbe E, Mancia G, et al. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. Eur J Intern Med. 2020;80:1\u201311.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"8180_CR188","first-page":"27","volume":"58","author":"T Pascart","year":"2019","unstructured":"Pascart T, Liot\u00e9 F. Gout: state of the art after a decade of developments. Rheumatology (Oxford). 2019;58(1):27\u201344.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"8180_CR189","doi-asserted-by":"publisher","first-page":"631","DOI":"10.55563\/clinexprheumatol\/2rn9fv","volume":"40","author":"N Schlesinger","year":"2022","unstructured":"Schlesinger N, Elsaid MI, Rustgi VK. The relationship between metabolic syndrome severity and the risk of mortality in gout patients: a population-based study. Clin Exp Rheumatol. 2022;40(3):631\u20133.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"8180_CR190","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.dsx.2018.06.015","volume":"12","author":"M Doualla-Bija","year":"2018","unstructured":"Doualla-Bija M, Lobe Batchama Y, Moutchia-Suh J, Ama Moor VJ, Kamdem F, Lekpa FK, et al. Prevalence and characteristics of metabolic syndrome in gout patients in a hospital setting in sub-Saharan Africa. Diabetes Metab Syndr. 2018;12(6):1007\u201311.","journal-title":"Diabetes Metab Syndr"},{"key":"8180_CR191","doi-asserted-by":"crossref","unstructured":"Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. Int J Mol Sci. 2021;22(17).","DOI":"10.3390\/ijms22179221"},{"issue":"6","key":"8180_CR192","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/1756-185X.12007","volume":"15","author":"TA Gheita","year":"2012","unstructured":"Gheita TA, El-Fishawy HS, Nasrallah MM, Hussein H. Insulin resistance and metabolic syndrome in primary gout: relation to punched-out erosions. Int J Rheum Dis. 2012;15(6):521\u20135.","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"8180_CR193","first-page":"807","volume":"38","author":"L Punzi","year":"2020","unstructured":"Punzi L, Scanu A, Galozzi P, Luisetto R, Spinella P, Scir\u00e8 CA, et al. One year in review 2020: gout. Clin Exp Rheumatol. 2020;38(5):807\u201321.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"8180_CR194","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1007\/s10067-021-05595-w","volume":"40","author":"J Liang","year":"2021","unstructured":"Liang J, Jiang Y, Huang Y, Huang Y, Liu F, Zhang Y, et al. Comorbidities and factors influencing frequent gout attacks in patients with gout: a cross-sectional study. Clin Rheumatol. 2021;40(7):2873\u201380.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"8180_CR195","doi-asserted-by":"publisher","first-page":"14364","DOI":"10.1002\/jcp.28138","volume":"234","author":"Y Xie","year":"2019","unstructured":"Xie Y, Xu P, Liu K, Lin S, Wang M, Tian T, et al. Hyperuricemia and gout are associated with cancer incidence and mortality: A meta-analysis based on cohort studies. J Cell Physiol. 2019;234(8):14364\u201376.","journal-title":"J Cell Physiol"},{"key":"8180_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152095","volume":"57","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Jin T, Ni J, Huang L, Xie Y, He W, et al. Assessing the causal associations of obstructive sleep apnea with serum uric acid levels and gout: a bidirectional two-sample Mendelian randomization study. Semin Arthritis Rheum. 2022;57: 152095.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"8180_CR197","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s41927-021-00199-y","volume":"5","author":"J New-Tolley","year":"2021","unstructured":"New-Tolley J, Reynolds AC, Appleton SL, Gill TK, Lester S, Adams RJ, et al. Sleep disorders and gout in Australian adults. BMC Rheumatol. 2021;5(1):30.","journal-title":"BMC Rheumatol"},{"key":"8180_CR198","doi-asserted-by":"crossref","unstructured":"Chaudhary NS, Gaffo AL, Cushman M, Colantonio LD, Levitan EB, Judd SE, et al. Association Between Uric Acid and Stroke in the REgards Case-cohort Study. Stroke. 2019;50(Suppl_1):A188-A.","DOI":"10.1161\/str.50.suppl_1.188"},{"issue":"2","key":"8180_CR199","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1148\/radiology.173.2.2678257","volume":"173","author":"K Toyoda","year":"1989","unstructured":"Toyoda K, Miyamoto Y, Ida M, Tada S, Utsunomiya M. Hyperechoic medulla of the kidneys. Radiology. 1989;173(2):431\u20134.","journal-title":"Radiology"},{"issue":"4","key":"8180_CR200","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/ndt\/gfg140","volume":"18","author":"T Umekawa","year":"2003","unstructured":"Umekawa T, Chegini N, Khan SR. Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant. 2003;18(4):664\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"8180_CR201","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3899\/jrheum.200497","volume":"48","author":"JS Lee","year":"2021","unstructured":"Lee JS, Myung J, Lee HA, Hong S, Lee CK, Yoo B, et al. Risk of Cancer in Middle-aged Patients With Gout: A Nationwide Population-based Study in Korea. J Rheumatol. 2021;48(9):1465\u201371.","journal-title":"J Rheumatol"},{"issue":"3","key":"8180_CR202","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/jdv.15290","volume":"33","author":"SC Hu","year":"2019","unstructured":"Hu SC, Lin CL, Tu HP. Association between psoriasis, psoriatic arthritis and gout: a nationwide population-based study. J Eur Acad Dermatol Venereol. 2019;33(3):560\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8180_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108397","volume":"214","author":"LM Perez-Chada","year":"2020","unstructured":"Perez-Chada LM, Merola JF. Comorbidities associated with psoriatic arthritis: Review and update. Clin Immunol. 2020;214: 108397.","journal-title":"Clin Immunol"},{"issue":"8","key":"8180_CR204","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3899\/jrheum.170444","volume":"45","author":"N Schlesinger","year":"2018","unstructured":"Schlesinger N, Lu N, Choi HK. Gout and the Risk of Incident Erectile Dysfunction: A Body Mass Index-matched Population-based Study. J Rheumatol. 2018;45(8):1192\u20137.","journal-title":"J Rheumatol"},{"issue":"9","key":"8180_CR205","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00296-019-04365-x","volume":"39","author":"L Luo","year":"2019","unstructured":"Luo L, Xiang Q, Deng Y, Zhao S, Zhu Z, Liu Y, et al. Gout is associated with elevated risk of erectile dysfunction: a systematic review and meta-analysis. Rheumatol Int. 2019;39(9):1527\u201335.","journal-title":"Rheumatol Int"},{"issue":"4","key":"8180_CR206","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40618-021-01719-w","volume":"45","author":"A Sansone","year":"2022","unstructured":"Sansone A, Reisman Y, Jannini EA. Relationship between hyperuricemia with deposition and sexual dysfunction in males and females. J Endocrinol Invest. 2022;45(4):691\u2013703.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"8180_CR207","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/1756-185X.13443","volume":"22","author":"T Shimizu","year":"2019","unstructured":"Shimizu T, Hori H, Umeyama M, Shimizu K. Characteristics of gout patients according to the laterality of nephrolithiasis: A cross-sectional study using helical computed tomography. Int J Rheum Dis. 2019;22(4):567\u201373.","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"8180_CR208","first-page":"2189","volume":"32","author":"J Alvarez-Nemegyei","year":"2005","unstructured":"Alvarez-Nemegyei J, Medina-Escobedo M, Villanueva-Jorge S, Vazquez-Mellado J. Prevalence and risk factors for urolithiasis in primary gout: is a reappraisal needed? J Rheumatol. 2005;32(11):2189\u201391.","journal-title":"J Rheumatol"},{"issue":"3","key":"8180_CR209","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11926-007-0040-z","volume":"9","author":"SE Liebman","year":"2007","unstructured":"Liebman SE, Taylor JG, Bushinsky DA. Uric acid nephrolithiasis. Curr Rheumatol Rep. 2007;9(3):251\u20137.","journal-title":"Curr Rheumatol Rep"},{"key":"8180_CR210","doi-asserted-by":"crossref","unstructured":"GUTMAN AB. Uric acid nephrolithiasis in gout: predisposing factors. Annals of Internal Medicine. 1967;67(6):1133\u201348.","DOI":"10.7326\/0003-4819-67-6-1133"},{"issue":"10","key":"8180_CR211","first-page":"632","volume":"17","author":"A Ferry","year":"1985","unstructured":"Ferry A, Safir A, Melikian H. Ocular abnormalities in patients with gout. Ann Ophthalmol. 1985;17(10):632\u20135.","journal-title":"Ann Ophthalmol"},{"issue":"2","key":"8180_CR212","doi-asserted-by":"publisher","first-page":"139","DOI":"10.6032\/gnam.37.139","volume":"37","author":"D Khanna","year":"2013","unstructured":"Khanna D. American College of rheumatology guidelines for management of gout. GOUT AND NUCLEIC ACID METABOLISM. 2013;37(2):139.","journal-title":"GOUT AND NUCLEIC ACID METABOLISM"},{"issue":"3","key":"8180_CR213","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/archopht.1966.00970050369010","volume":"75","author":"RS Fishman","year":"1966","unstructured":"Fishman RS, Sunderman FW. Band keratopathy in gout. Arch Ophthalmol. 1966;75(3):367\u20139.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"8180_CR214","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/archopht.1968.00980050340008","volume":"80","author":"HH Slansky","year":"1968","unstructured":"Slansky HH, Kuwabara T. Intranuclear urate crystals in corneal epithelium. Arch Ophthalmol. 1968;80(3):338\u201344.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"8180_CR215","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ophtha.2005.11.012","volume":"113","author":"M Coassin","year":"2006","unstructured":"Coassin M, Piovanetti O, Stark WJ, Green WR. Urate deposition in the iris and anterior chamber. Ophthalmology. 2006;113(3):462\u20135.","journal-title":"Ophthalmology"},{"issue":"3","key":"8180_CR216","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0953-4431(96)00176-2","volume":"8","author":"F Burgos","year":"1996","unstructured":"Burgos F, Capone RC. Ocular and systemic manifestations of gout. Clinical Eye and Vision Care. 1996;8(3):155\u201363.","journal-title":"Clinical Eye and Vision Care"},{"issue":"2","key":"8180_CR217","first-page":"471","volume":"13","author":"E Martinez-Cordero","year":"1986","unstructured":"Martinez-Cordero E, Barreira-Mercado E, Katona G. Eye tophi deposition in gout. J Rheumatol. 1986;13(2):471\u20133.","journal-title":"J Rheumatol"},{"issue":"3","key":"8180_CR218","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.eye.6700334","volume":"17","author":"N Topping","year":"2003","unstructured":"Topping N, Cassels-Brown A, Chakrabarty A, Cronin P, Ross S, Russell J, et al. Uric acid crystals presenting as an orbital mass. Eye. 2003;17(3):427\u20139.","journal-title":"Eye"},{"issue":"5","key":"8180_CR219","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00296-008-0736-z","volume":"29","author":"F Y\u00fclek","year":"2009","unstructured":"Y\u00fclek F, \u00c7a\u011f\u0131l N, Orhan N, Midillio\u011flu \u0130K, Erten \u015e, \u015eim\u015fek \u015e. Gout attack with unusual ocular complications. Rheumatol Int. 2009;29(5):557\u20139.","journal-title":"Rheumatol Int"},{"issue":"1","key":"8180_CR220","first-page":"53","volume":"86","author":"M De Monteynard","year":"1986","unstructured":"De Monteynard M, Jacquier J, Adotti F, Bodard-Rickelman E. Gouty tophus of the eyelid. Bulletin des Societes D\u2019ophtalmologie de France. 1986;86(1):53\u20134.","journal-title":"Bulletin des Societes D'ophtalmologie de France"},{"issue":"5","key":"8180_CR221","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/IOP.0b013e3181837a31","volume":"24","author":"DR Jordan","year":"2008","unstructured":"Jordan DR, Belliveau MJ, Brownstein S, McEachren T, Kyrollos M. Medial canthal tophus. Ophthalmic Plast Reconstr Surg. 2008;24(5):403\u20134.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"8","key":"8180_CR222","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/archopht.121.8.1195","volume":"121","author":"WR Morris","year":"2003","unstructured":"Morris WR, Fleming JC. Gouty tophus at the lateral canthus. Arch Ophthalmol. 2003;121(8):1195\u20137.","journal-title":"Arch Ophthalmol"},{"key":"8180_CR223","unstructured":"Mikkilineni S, Schlachter DM. Rare case of gout manifesting as bilateral eyelid lesions. 2020."},{"issue":"5","key":"8180_CR224","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/IOP.0b013e318182a538","volume":"24","author":"CCL Yang","year":"2008","unstructured":"Yang CCL, Vagefi MR, Davis D, Mamalis N, Anderson RL, McCann J. Gouty tophus of the upper eyelid. Ophthalmic Plast Reconstr Surg. 2008;24(5):404\u20136.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"8180_CR225","unstructured":"Berman E. Clues in the eye: ocular signs of metabolic and nutritional disorders. Geriatrics (Basel, Switzerland). 1995;50(7):34\u20136, 43."},{"key":"8180_CR226","first-page":"473","volume":"6","author":"CS Bull","year":"1893","unstructured":"Bull CS. Gouty Retinitis, Chorio-Retinitis, and Neuro-Retinitis. Trans Am Ophthalmol Soc. 1893;6:473.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"5","key":"8180_CR227","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/archopht.121.5.674","volume":"121","author":"R Klein","year":"2003","unstructured":"Klein R, Klein BE, Tomany SC, Cruickshanks KJ. Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy. Arch Ophthalmol. 2003;121(5):674\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"8180_CR228","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/OPX.0b013e318181a947","volume":"85","author":"SE Moss","year":"2008","unstructured":"Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci. 2008;85(8):668\u201374.","journal-title":"Optom Vis Sci"},{"issue":"9","key":"8180_CR229","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","volume":"118","author":"SE Moss","year":"2000","unstructured":"Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"8180_CR230","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1442-9071.2003.00634.x","volume":"31","author":"EM Chia","year":"2003","unstructured":"Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol. 2003;31(3):229\u201332.","journal-title":"Clin Exp Ophthalmol"},{"issue":"434","key":"8180_CR231","first-page":"2","volume":"6","author":"A Kwok","year":"2015","unstructured":"Kwok A, Yam J, Ting J, Ng D, Kwok V, Chen Y. Simultaneous central retinal vein occlusion and branch retinal artery occlusion in a young patient with gout. J Clin Exp Ophthalmol. 2015;6(434):2.","journal-title":"J Clin Exp Ophthalmol"},{"key":"8180_CR232","doi-asserted-by":"crossref","unstructured":"Laval J. Allopurinol and macular lesions. Archives of Ophthalmology. 1968;80(3):415-.","DOI":"10.1001\/archopht.1968.00980050417028"},{"issue":"10","key":"8180_CR233","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.3390\/jcm9103204","volume":"9","author":"P Khanna","year":"2020","unstructured":"Khanna P, Johnson RJ, Marder B, LaMoreaux B, Kumar A. Systemic urate deposition: an unrecognized complication of gout? J Clin Med. 2020;9(10):3204.","journal-title":"J Clin Med"},{"issue":"4","key":"8180_CR234","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/ard.9.4.282","volume":"9","author":"GD Kersley","year":"1950","unstructured":"Kersley GD, Mandel L, Jeffrey MR. Gout; an unusual case with softening and subluxation of the first cervical vertebra and splenomegaly. Ann Rheum Dis. 1950;9(4):282\u2013304.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8180_CR235","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1590\/S0482-50042013000300008","volume":"53","author":"EM Hasegawa","year":"2013","unstructured":"Hasegawa EM, de Mello FM, Goldenstein-Schainberg C, Fuller R. Gout in the spine. Rev Bras Reumatol. 2013;53(3):296\u2013302.","journal-title":"Rev Bras Reumatol"},{"issue":"3","key":"8180_CR236","doi-asserted-by":"publisher","first-page":"185","DOI":"10.14245\/kjs.2013.10.3.185","volume":"10","author":"JW Yoon","year":"2013","unstructured":"Yoon JW, Park KB, Park H, Kang DH, Lee CH, Hwang SH, et al. Tophaceous gout of the spine causing neural compression. Korean J Spine. 2013;10(3):185\u20138.","journal-title":"Korean J Spine"},{"issue":"12","key":"8180_CR237","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11926-015-0547-7","volume":"17","author":"M Toprover","year":"2015","unstructured":"Toprover M, Krasnokutsky S, Pillinger MH. Gout in the Spine: Imaging, Diagnosis, and Outcomes. Curr Rheumatol Rep. 2015;17(12):70.","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"8180_CR238","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/art.10067","volume":"46","author":"D Khanna","year":"2002","unstructured":"Khanna D, Tang SJ, Wallace WD, Roth BE, Hahn BH. Gouty tophi in a pancreatic pseudocyst. Arthritis Rheum. 2002;46(2):565\u20136.","journal-title":"Arthritis Rheum"},{"key":"8180_CR239","doi-asserted-by":"crossref","unstructured":"Sarungbam J, Jain S, Yusuf Y. Urate Crystals in Pancreatic Pseudocyst:A Rare Cause of Intestinal Perforation. American Journal of Clinical Pathology. 2012;138:A235-A.","DOI":"10.1093\/ajcp\/138.suppl1.219"},{"issue":"3","key":"8180_CR240","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/ard.24.3.224","volume":"24","author":"CF Hawkins","year":"1965","unstructured":"Hawkins CF, Ellis HA, Rawson A. MALIGNANT GOUT WITH TOPHACEOUS SMALL INTESTINE AND MEGALOBLASTIC ANAEMIA. Ann Rheum Dis. 1965;24(3):224\u201333.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"8180_CR241","first-page":"499","volume":"24","author":"P Hanova","year":"2006","unstructured":"Hanova P, Pavelka K, Dostal C, Holcatova I, Pikhart H. Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002\u20132003. Clin Exp Rheumatol. 2006;24(5):499\u2013507.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"8180_CR242","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.humpath.2004.04.003","volume":"35","author":"H Wu","year":"2004","unstructured":"Wu H, Klein MJ, Stahl RE, Sanchez MA. Intestinal pseudotumorous gouty nodulosis: a colonic tophus without manifestation of gouty arthritis. Hum Pathol. 2004;35(7):897\u20139.","journal-title":"Hum Pathol"},{"issue":"4","key":"8180_CR243","first-page":"33","volume":"4","author":"P Pattanaprichakul","year":"2014","unstructured":"Pattanaprichakul P, Bunyaratavej S, McLain PM, Varothai S. Disseminated gouty panniculitis: an unusual presentation of extensive cutaneous tophi. Dermatol Pract Concept. 2014;4(4):33\u20135.","journal-title":"Dermatol Pract Concept"},{"issue":"2","key":"8180_CR244","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5152\/iao.2016.1293","volume":"12","author":"A Mutlu","year":"2016","unstructured":"Mutlu A, D\u00fcndar E, \u0130\u015feri M, Er\u00e7in C, Cefle A. An Unusual Presentation of Gout: Tophi in the Middle Ear. J Int Adv Otol. 2016;12(2):216\u20138.","journal-title":"J Int Adv Otol"},{"issue":"12","key":"8180_CR245","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1055\/s-2007-1008501","volume":"62","author":"I Faas","year":"1983","unstructured":"Faas I. A gouty tophus in the temporomandibular joint and on the eustachian tube. Laryngol Rhinol Otol (Stuttg). 1983;62(12):574\u20137.","journal-title":"Laryngol Rhinol Otol (Stuttg)"},{"issue":"12","key":"8180_CR246","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1164\/rccm.201301-0097IM","volume":"188","author":"R Adamson","year":"2013","unstructured":"Adamson R, Lacy JM, Cheng AM, Park DR. Tophus causing bronchial obstruction. Am J Respir Crit Care Med. 2013;188(12):e72\u20133.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"8180_CR247","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1075-122X.2006.00252.x","volume":"12","author":"MA Sharifabad","year":"2006","unstructured":"Sharifabad MA, Tzeng J, Gharibshahi S. Mammary gouty tophus: a case report and review of the literature. Breast J. 2006;12(3):263\u20135.","journal-title":"Breast J"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-024-08180-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-024-08180-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-024-08180-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T15:08:00Z","timestamp":1734620880000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-024-08180-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":247,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8180"],"URL":"https:\/\/doi.org\/10.1186\/s12891-024-08180-9","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"11 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present report was approved by the Ethics Committee at the Shahid Beheshti University of Medical Sciences (IR.SBMU.RETECH.REC.1401.216).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1047"}}